Prospective Study of Personalized Approach to Inpatient Patients With Hyperglycemia
Status:
Active, not recruiting
Trial end date:
2022-04-03
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the outcomes between hospitalized cancer patients
with high blood sugar receiving the current standard of care of administering insulin, and
hospitalized cancer patients receiving a new, individualized method of insulin
administration.
Phase:
Early Phase 1
Details
Lead Sponsor:
H. Lee Moffitt Cancer Center and Research Institute